Search clinical trials for: TAK-925+Placebo

Total 58704 results

University Hospital, Lille
Ministry of Health, France; French Health Products Safety Agency

Terminated

Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery (TRACES)

Hemorrhage | Pregnancy Complications

France
Takeda

Terminated

TAK-071 Scopolamine-Induced Cognitive Impairment Study

Healthy Volunteers

United States
Zealand University Hospital

Completed

Do we Achieve the Goal of "No Worse Than Mild Pain" in Daily Clinical Practice?

Pain, Postoperative

Denmark
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors

Advanced Solid Neoplasm

United States
Cassava Sciences, Inc.
National Institute on Aging (NIA)

Completed

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients (PTI-125)

Alzheimer Disease

United States, Canada
Takeda

Completed

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
Millennium Pharmaceuticals, Inc.

Completed

A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors

Advanced Solid Tumors, Neoplasms, Advanced Solid

Hungary
Durect
CTI Clinical Trial and Consulting Services

Completed

A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (AHFIRM)

Alcoholic Hepatitis

United States, Australia, United Kingdom, France, Belgium, Austria
Takeda

Terminated

Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia

Schizophrenia

United States
Hôpital le Vinatier

Not yet recruiting

Cannabidiol for Reducing Drinking in Alcohol Use Disorder (CARAMEL)

Alcohol Use Disorder

France
Centre Hospitalier National d'Ophtalmologie des...

Recruiting

Mobility Protocol Adapted for Advanced Visually Impaired Subjects (PROMA)

Pigmentary Retinopathy

France
Fundació Sant Joan de Déu
Universitat Autonoma de Barcelona

Recruiting

Mindfulness and Cognitive Training Programs for Children With ADHD (the NeuroMind Study) (NeuroMind)

ADHD

Spain
Takeda

Completed

Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
InQpharm Group

Completed

Safety and Efficacy of IQP- AK-102 in Reducing Body Weight

Weight Loss

Germany
InQpharm Group

Completed

Safety and Efficacy of IQP-AK-102 in Reducing Appetite

Weight Loss | Appetite Modulation (Focus of Study)

Germany
Millennium Pharmaceuticals, Inc.

Completed

A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

Neoplasms, Advanced Solid

Netherlands
Takeda

Completed

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

Healthy Volunteers

Japan
Takeda

Completed

A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids

Uterine Fibroids

Japan
Soonchunhyang University Hospital

Unknown

Transversus Abdominis Plane Block and Postoperative Pain After Laparoscopic Cholecystectomy

Postoperative Pain | Laparoscopic Cholecystectomy | Abdominal Muscles | Nerve Block

Korea, Republic of
Centro Mente Aberta de Mindfulness
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Mindfulness Intervention for Overweight Primary Care Patients (MindEat)

Obesity | Overweight

Brazil
Aptinyx
Syneos Health

Completed

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

Diabetic Peripheral Neuropathy

United States
Takeda

Terminated

A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults

Hypertension

United States, United Kingdom
Gilead Sciences

Recruiting

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy (ARTISTRY-2)

HIV-1-infection

United States
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）

Duchenne Muscular Dystrophy

Japan
Toray Industries, Inc

Completed

Phase II Study of TRK-820 Soft Capsules - Intractable Pruritus in Patients With Chronic Liver Disease -

Pruritus With Chronic Liver Disease

Japan
Takeda

Completed

An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063

Healthy Volunteers
Gilead Sciences

Completed

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed

HIV-1-infection

United States, Puerto Rico, France, Germany, Austria, Canada
Zhejiang Hisun Pharmaceutical Co. Ltd.
Covance

Completed

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

Primary Hypercholesterolemia

United States
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study (TOBABTK)

Peripheral Artery Disease | Critical Limb Ischemia

Austria
Takeda

Recruiting

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Colorectal Cancer | Non-small Cell Lung Cancer (NSCLC) | Squamous Cell Cancer of Head and Neck (SCCHN)

Korea, Republic of, United States, Australia
Takeda

Enrolling by invitation

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Alpha1-Antitrypsin Deficiency

United Kingdom, Germany, United States, Austria, Portugal
Takeda

Available

Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)

Von Willebrand Disease (VWD)
Millennium Pharmaceuticals, Inc.

Completed

Safety Study of TAK-700 in Subjects With Prostate Cancer. (TAK-700)

Prostatic Neoplasms

United States
Takeda

Completed

A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants

Healthy Volunteers

China
Takeda

Completed

Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States, Mexico, Guatemala
Takeda

Not yet recruiting

A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements

Healthy Volunteers
University of Sao Paulo

Completed

Real and Virtual Environments in Autism Spectrum Disorder

Autism Spectrum Disorder

Brazil
Zydus Lifesciences Limited

Recruiting

Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

India
Maastricht Radiation Oncology
Cardiff University; Radboud University Medical Center; Fudan University; University... and other collaborators

Completed

20K Distributed Learning Challenge

Non Small Cell Lung Cancer

Netherlands
Takeda

Completed

Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
Canopy Growth Corporation
Centre hospitalier de l'Université de Montréal (CHUM); McGill University Health... and other collaborators

Terminated

Investigation of the Efficacy and Safety of CHI-921 in Insomnia.

Insomnia

Canada
Takeda

Completed

Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia

Balance

United Kingdom
Tel-Aviv Sourasky Medical Center

Unknown

Probiotics and Microbiota in Bariatric Surgery

NAFLD

Israel
Grifols Therapeutics LLC

Completed

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis (PRIVIG)

Multiple Sclerosis, Relapsing-Remitting

Canada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
The University of Tennessee, Knoxville
Smith & Nephew, Inc.

Completed

Analysis of Competitive Posterior Cruciate Retaining (PCR) and Posterior Stabilized (PS) Total Knee Arthroplasty (TKA)

Knee Osteoarthritis | Total Knee Arthroplasty | Knee

United States
University of Washington
United States Department of Defense; Military Suicide Research Consortium

Completed

Military Continuity Project (MCP)

Suicidal and Self-injurious Behavior | Suicidal Ideation Active

United States
Pfizer

Completed

A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults

Healthy

United States
Takeda

Active, not recruiting

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma (iinnovate-3)

Multiple Myeloma

Spain, United States, Australia, China, Korea, Republic of, Canada, France
Takeda

Terminated

A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants

Healthy Volunteers

United States
Wockhardt
Clinartis, LLC

Completed

To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)

Antibiotics Causing Adverse Effects in Therapeutic Use

United States

3

Subscribe